Skip to main content
SpringerLink
Log in

Reply to the Letter to the editors by A. Maghazachi

  • Letter to the editors
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Basse PH, Nannmark U, Johansson BR, Herberman RG, Goldfarb RH (1991) Establishment to cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. J Natl Cancer Inst 83: 944

    PubMed  Google Scholar 

  2. Basse P, Herberman RB, Nannmark U, Johansson BR, Hokland M, Wasserman K, Goldfarb RH (1991) Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J Exp Med 174: 479

    PubMed  Google Scholar 

  3. Basse PH, Herberman RB, Hokland ME, Goldfarb RH (1992) Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels. Cancer Immunol Immunother 34: 221

    Google Scholar 

  4. Basse PH, Herberman RB, Hokland ME, Goldfarb RH (1992) Tissue distribution of adoptively transferred adherent LAK cells: role of route of administration. Nat Immun Cell Growth Regul (in press)

  5. Bernal SD, Lampidis TJ, Summerhayes IC, Chen LB (1982) Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. Science 218: 1117

    PubMed  Google Scholar 

  6. Butcher EC, Weissman IL (1980) Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate: II. Potential application to studies of lymphocyte migration and maturation. J Immunol Methods 37: 109

    PubMed  Google Scholar 

  7. Butcher EC, Weissman IL (1980) Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate: 1. Technical aspects. J Immunol Methods 37: 97

    PubMed  Google Scholar 

  8. Fisher B, Packard BS, Read EJ, Carrasquillo JA, Carter CS, Topalian SL, Yang JC, Yolles P, Larson SM, Rosenberg SA (1989) Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol 7: 250

    PubMed  Google Scholar 

  9. Johnson LV, Walsh ML, Chen LB (1980) Localization of Mitochondria in living cells with rhodamine-123. Proc Natl Acad Sci USA 77: 990

    PubMed  Google Scholar 

  10. Lampidis TJ, Bernal SD, Summerhayes IC, Chen LB (1983) Selective toxicity of Rhodamine 123 in carcinoma cells in vitro. Cancer Res 43: 716

    PubMed  Google Scholar 

  11. Maghazachi AA, Fitzgibbon L (1990) Fate of intravenously administered ray lymphokine-activated killer cells labeled with different markers. Cancer Immunol Immunother 31: 139

    PubMed  Google Scholar 

  12. Maghazachi AA, Herberman RB, Vujanovic NL, Hiserodt JC (1988) In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells. Cell Immunol 115: 179

    PubMed  Google Scholar 

  13. Maghazachi AA, Goldfarb RH, Kitson RP, Hiserodt JC, Giffen CA, Herberman RB (1990) In vivo distribution of interleukin-2 activated cells. In: Lotzova E, Herberman RB (eds) Interleukin-2 and killer cells in cancer. CRC Reviews. CRC, Boca Raton, Fla, p 260

    Google Scholar 

  14. Ratner S (1990) Lymphocytes stimulated with recombinant human interleukin-2: relationship between motility into protein matrix and in vivo localization in normal and neoplastic tissues of mice. J Natl Cancer Inst 82: 612

    Google Scholar 

  15. Wiltrout RH, Gorelik E, Brunda MJ, Holden HT, Herberman RB (1983) Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of125I-iododeoxyuridine with111indium-oxine and51chromium as cell labels. Cancer Immunol Immunother 14: 172

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pittsburgh Cancer Institute, Division of Basic Research, Biomedical Science Tower, DeSoto at O'Hara Streets, 15 213, Pittsburgh, PA, USA

    Per Basse, Ronald B. Herberman, Marianne Hokland & Ronald H. Goldfarb

Authors
  1. Per Basse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald B. Herberman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marianne Hokland
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ronald H. Goldfarb
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Basse, P., Herberman, R.B., Hokland, M. et al. Reply to the Letter to the editors by A. Maghazachi. Cancer Immunol Immunother 35, 428–430 (1992). https://doi.org/10.1007/BF01789024

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01789024

Keywords

Search

Navigation